BRIEF-Contravir Pharmaceuticals announced new data demonstrating clinical antiviral activity and safety, pharmacokinetic data of tenofovir exalidex

* Contravir Pharmaceuticals - Announced new data demonstrating clinical antiviral activity and safety, pharmacokinetic data of tenofovir exalidex
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.